Inbiomotion and SPA - Società Prodotti Antibiotici (SPA Farma) sign an exclusive agreement for MAF Test® in Italy

by Inbiomotion

2 hours ago
Inbiomotion, SPA Farma, MAF Test®, bisphosphonates, breast cancer, MAF

This pioneering test aids oncologists in predicting recurrence and survival rates in breast cancer patients and potential eligibility for bisphosphonate treatment.

The ELISAH project takes a pragmatic approach to address breast cancer prevention

by Universitat de Girona

7 months ago
ELISAH project, breast cancer

Multidisciplinary experts will conduct a thorough analysis of national cancer plans and design innovative interventions that will be tailored to specific regions.

A study by ibs.GRANADA reveals that exposure to metal mixtures could significantly increase the risk of breast cancer

by Instituto de Investigación Biosanitaria - Ibs Granada

9 months ago
breast cancer, metal mixtures

The research, led by experts in cancer epidemiology from the Biosanitary Research Institute ibs.GRANADA, analyzed exposure to 16 heavy metals and semimetals in 578 women from four Spanish provinces.

Researchers at CNIO and IDIBELL shed light on the role in lactation of a protein also crucial in breast cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

1 year ago
RANK protein, luminal alveolar cells, breast cancer, lactation

The new study, led by Eva González-Suárez, head of the Transformation and Metastase Group at the Spanish National Cancer Research Centre (CNIO), describes the behaviour and interaction of these two ...

ibs.GRANADA scientists demonstrate the important role of endocrine therapy in the treatment of breast cancer

by Instituto de Investigación Biosanitaria - Ibs Granada

2 years ago
Abemaciclib, therapy endocrine, breast cancer, positive estrogen receptors and Her-2 negative, MonarchE

It has been shown that the therapy endocrine, combined with a drug used in breast cancer called Abemaciclib, means a treatment with greater safety and better results perceived by patients in the treat...

A pre-disease anti-diabetic and anti-inflammatory diet may contribute to a better prognosis in breast cancer survivors

by ICO - Institut Català d'Oncologia

2 years ago
anti-diabetic and anti-inflammatory diet, breast cancer

A study led by researchers from the Nutrition and Cancer Unit of the Catalan Institute of Oncology and the Biomedical Research Institute of Bellvitge (IDIBELL), published in the scientific journal ...

Artificial intelligence in breast cancer treatment

by Universitat de Barcelona

2 years ago
RadioVal, breast cancer, Artificial intelligence

The University of Barcelona is leading a European project to clinically validate an Artificial Intelligence solution to predict the specific response of each patient in breast cancer chemotherapy.

A new treatment is effective for advanced HER2-low breast cancer

by Fundació Clínic per a la Recerca Biomèdica

2 years ago
HER2, breast cancer, trastuzumab deruxtecan

Researchers from the Hospital Clínic-IDIBAPS, the Catalan Institute of Oncology (ICO)-IDIBELL and the Vall d’Hebron Institute of Oncology (VHIO), which forms part of the Vall d’Hebron Campus, par...

A selection of VHIO research highlights at the San Antonio Breast Cancer Symposium 2021

by VHIO

3 years ago
Cancer, VHIO, Breast Cancer, Research

Among the many studies that counted on the participation of VHIO researchers and clinical investigators at VHIO as first and/or co-authors were several clinical trials developed by the SOLTI academic ...

Breast cancer cells create collagen shields to protect themselves from the immune system

by Hospital Universitari de Bellvitge

3 years ago
immune cells, Breast cancer, mammary tumor

The high number of immune cells within tumors is an indicator of a good prognosis, since they attack the tumor and help destroy it.

Seeking out predictive biomarkers to FGFR inhibitors in molecularly-selected metastatic breast cancer

by Vall d’Hebron

3 years ago
breast cancer, FGFR inhibitors

Recently published in Clinical Cancer Research*, results from patient-derived xenografts (PDXs) and breast cancer patient samples support the prospective validation of this approach in luminal CDK...